NOTE 5 - CAPITAL STOCK (Details) - USD ($)			1 Months Ended	9 Months Ended
	Apr. 02, 2019	Dec. 31, 2014	Mar. 31, 2015	Sep. 30, 2019	Sep. 30, 2020	Dec. 31, 2019
Common Stock, Shares Authorized					100,000,000	100,000,000
Common Stock, Par or Stated Value Per Share					$ 0.0001	$ 0.0001
Preferred Stock, Par or Stated Value Per Share					$ 0.0001
Proceeds from sales of shares	$ 14,490			$ 16,288
Restricted common stock issued	21,000
Redfield Holdings, Ltd
Preferred Stock, Voting Rights			Each share of preferred shares – Series “A” carries voting right equal to 10,000 common shares
Convertible Notes Payable | Redfield Holdings, Ltd
Amount Subscribed By Related Party Against Cancellation Of Note			$ 58,000
GS Pharmaceuticals, Inc.
Principal amount of note outstanding		$ 330,000
Preferred Class A
Preferred Stock, Shares Authorized					20,000,000	20,000,000
Preferred Stock, Par or Stated Value Per Share					$ 0.0001	$ 0.0001
Preferred Stock, Shares Issued					10,000	10,000
Preferred Stock, Shares Outstanding					10,000
Series B Preferred Stock
Redeemable Preferred Stock, Shares Authorized					500,000	500,000
Redeemable Preferred Stock, Shares Issued					330,000	0
Redeemable Preferred Stock, Shares Outstanding					330,000	0
Series B Preferred Stock | GS Pharmaceuticals, Inc.
Preferred shares issued upon conversion of debt		330,000